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Background: The objective of this research is to generate quality of care indicators from systematic reviews to
assess the appropriateness of obstetric care in hospitals.
Methods: A search for systematic reviews about hospital obstetric interventions, conducted in The Cochrane
Library, clinical evidence and practice guidelines, identified 303 reviews. We selected 48 high-quality evidence
reviews, which resulted in strong clinical recommendations using the Grading of Recommendations Assessment,
Development and Evaluation (GRADE) system. The 255 remaining reviews were excluded, mainly due to a lack of
strong evidence provided by the studies reviewed.
Results: A total of 18 indicators were formulated from these clinical recommendations, on antepartum care (8),
care during delivery and postpartum (9), and incomplete miscarriage (1). Authors of the systematic reviews and
specialists in obstetrics were consulted to refine the formulation of indicators.
Conclusions: High-quality systematic reviews, whose conclusions clearly claim in favour or against an intervention,
can be a source for generating quality indicators of delivery care. To make indicators coherent, the nuances of
clinical practice should be considered. Any attempt made to evaluate the extent to which delivery care in hospitals
is based on scientific evidence should take the generated indicators into account.
Keywords: Quality improvement methodologies, Quality indicators, Healthcare, Evidence-based medicine,
Obstetrics and gynaecology, Evaluation methodologyBackground
Quality of care has been defined as the degree to which
health services increase the likelihood of desired health
outcomes for individuals and populations and are con-
sistent with current professional knowledge [1]. Scien-
tific knowledge is not the only component of the quality
of care that must be taken into account, as other struc-
tural factors such as process or outcome are also import-
ant. In addition, local and particular circumstances of
each situation and patients’ preferences cannot be ig-
nored when assessing the appropriateness of a decision
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reproduction in any medium, provided the orthe filter of scientific evidence is an essential enterprise,
coherent with the goals of a public health system, the
ethical principles of health professionals and the basic
rights of citizens, given the possibility that patients
might receive inappropriate health care [3,4].
Too little attention has been paid to the correlation
between the availability of scientific evidence and clinical
practice. A series of studies [5-7] faced the burden of
having to analyse de novo the evidence relevant to each
case. The establishment of a priori clinical indicators to
be used as performance measures might be more effi-
cient for systematically assessing the degree to which
scientific evidence is applied in clinical practice.
Development of indicators based on professional con-
sensus has a long history [8,9], while systematic and expli-
cit methods to incorporate scientific evidence have been
developed to a lesser extent. Some recent initiatives, how-
ever, followed a systematic approach [10]. Moreover, atd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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combines scientific evidence with professional consensus:
the process starts with defining topics of interest, con-
tinues with selecting available evidence from different
sources, and ends with formulating indicators that are
ultimately evaluated by panels of experts through a struc-
tured consensus method [11].
In the present study, we restricted the source of indi-
cators of quality of care to systematic reviews (SR),
based on the assumption that they provide the highest
degree of reliability [12], are increasingly available, and
that decision makers increasingly rely on them to cope
with the ever-growing volume of healthcare research.
Obstetric care during childbirth is particularly suitable
for evaluation through evidence-based indicators be-
cause it is a field with a relatively high production of
SRs. The Cochrane Pregnancy and Childbirth Cochrane
Review Group had published hundreds of full SRs,
which have been the basis for numerous recommenda-
tions and clinical practice guidelines (CPGs) [13]. In
addition, some authors have challenged many indicators
currently used in obstetrics; a recent study analysed the
main indicators currently available (176 in total) and
concluded that most did not meet the requirements to
measure quality of care [14]. Similar results have been
reported in other areas of healthcare [10].
In summary, we generated a set of quality indicators
of obstetric care related to childbirth, based on SRs,
which could be applicable in different settings and
circumstances.
Methods
The first phase of our project consisted of a literature
search and generation of a set of recommendations
based on sound evidence, either in favour or againstTable 1 First phase: generation of clinical recommendations f
1. Literature search Design and execution of a s
2. Selection of SR SR were included based on
o Field of interest: obstetric
o Setting: hospital
o Relevant to the health to
o Intervention of interest: p
responsibility of the clinical
3. Appraisal of SR An assessment of the meth
not meet one or more inter
4. Generation of clinical
recommendations (CR)
Generation of a clinical reco
Definitions were provided f
5. Grading of
Recommendations
Assessment of the quality o
system. Only those recomm
evidence remained selected
*SIGN: Scottish Intercollegiate Guidelines Network; †GRADE: Grading of Recommendatinterventions in delivery care; the second phase consisted
of developing and validating a set of indicators.First phase
Table 1 summarizes the sequential steps followed in the
first phase. This mainly consisted of identifying evidence,
appraising literature, and generating and grading clinical
recommendations. Only SRs of randomized clinical trials
were considered.Literature search
A literature search was conducted in the Cochrane Data-
base of Systematic Reviews (The Cochrane Library, Issue
3, 2009, and updated in 2011), the Database of Abstracts
of Reviews of Effects, and Clinical Evidence to identify
SRs assessing obstetric interventions performed in a hos-
pital setting. To retrieve supplementary relevant SR, we
consulted the available CPG from the main obstetrical
medical societies (the Royal College of Obstetricians and
Gynaecologists, the American College of Obstetricians
and Gynaecologists) and CPG of obstetric care from
main guideline producers (the National Institute for
Clinical Excellence (NICE), and the New Zealand Guide-
lines Group).Selection of systematic reviews
Two researchers (MA and DR) independently applied
selection criteria to the identified SR: pharmacological or
non-pharmacological interventions, under the responsi-
bility of the clinical team and registered at the clinical
record or any other database. In case of disagreement,
the criterion from a third author (XB) was applied.rom systematic reviews




harmacological or non-pharmacological treatment, under the
team and potentially registered at the clinical record or any database.
odological quality of each SR; we excluded those documents that did
nal validity criteria of SIGN*.
mmendation (for or against a particular intervention) from each SR.
or population, intervention, comparison and outcomes of interest.
f evidence and strength of recommendation based on the GRADE†
endations that were considered strong and supported by high quality
.
ions Assessment, Development and Evaluation.
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Two researchers (MA and DR) independently appraised
each SR and restricted the inclusion to SR that met all
internal validity items established by the Scottish Inter-
collegiate Guidelines Network (SIGN) [15], as assessed
on the review’s full text. These criteria assess whether a
formulated question is clearly addressed, a description of
the methodology is included, the search strategy is suffi-
ciently rigorous, the quality of individual studies is
analysed and taken into account, heterogeneity is evalu-
ated and the original authors tried to explain it.
Generation and grading of recommendations
For each selected SR, we classified the outcomes by rele-
vance (critical, important and relative). Two authors
(MA and DR) independently rated the quality of evi-
dence and assessed the strength of recommendations
based on the Grading of Recommendations Assessment,
Development and Evaluation (GRADE) system [16]. Ap-
plicability of the GRADE system to generate quality indi-
cators has been described previously [17,18]. Quality of
evidence of critical outcomes was rated high, moderate,
low or very low, based on: limitations in design of the
primary studies; imprecision, inconsistency and indirect-
ness of the estimates of effects; and likelihood of
reporting bias and other biases. A set of clinical recom-
mendations was generated based on balancing the desir-
able and undesirable consequences of an intervention
and the quality of evidence. We used an adaptation of
GRADE system, and patients’ values, preferences and
resource use were not considered because they are
context-specific. Additional file 1: Table S4 shows the
modified GRADE system we applied.
Two authors (MA and DR) independently selected
recommendations that were considered strong (either in
favour or against the application of a given intervention)
and based on high quality evidence, at least for the most
critical outcomes. In case of disagreements, a third au-
thor (XB) was consulted.
Second phase
Development and validation of indicators
From the selected clinical recommendations, we procee-
ded to construct indicators, following an adaptation of
the methods proposed by the American College of Car-
diology/American Heart Association (ACC/AHA) [19]
and the Agency for Healthcare Research and Quality
(AHRQ) [20]. Table 2 shows the general structure of an
indicator and the sources of information for each sec-
tion. Most of the information came either from the SR
or current guidelines that summarize both evidence and
clinical expertise. Specific sections such as the identifica-
tion of sources of information to compute the indicator,
factors that may explain variability in the results, andspecific setting characteristics to ensure the viability of
the indicator were needed from clinical experts’ input as
well as additional supporting literature.
We subsequently consulted two specialists in obstet-
rics (CF and AV) to assess our design interpretation of
the indicators, and the relevance of the indicators in
current practice. This was followed by an email consult-
ation with the authors of the SR on which the indicators
were based, asking to what extent they agreed with the
formulation of the indicator (content validity, robustness
and reliability). The comments received from the review
authors or consultants led us to modify or redefine vari-
ous indicators.
Results
Search and selection of systematic reviews
Figure 1 shows the study flowchart. We identified 303
SR, 301 from the search in The Cochrane Library and 2
more [21,22] from the CPG consulted; 102 were ex-
cluded for not targeting acute care interventions, 149 for
not providing clear evidence (there was no benefit/harm
associated with the intervention), and 4 because inter-
ventions were not implemented by clinical teams, or the
clinical processes were not sufficiently measurable.
Then, 48 SR were provisionally selected for further con-
sideration [21-43].
Quality of evidence assessment and generation of clinical
recommendations
The selected reviews consisted exclusively of Cochrane
reviews. No SR was excluded based on their quality as-
sessment. In the following stage, 28 SR were excluded
for not providing a base for any strong recommendation
(either in favour or against an intervention). Thus, we
generated 20 clinical recommendations that were both
strong and based on high-quality evidence.
Construction and validation of indicators
Approximately 75% of the authors of the selected SR
responded to our request to review the indicator. Over-
all, they agreed on the indicator proposal, and their
comments were used for further improvement of their
definition and formulation.
Following advice of the obstetric consultants, two indi-
cators were removed: the proportion of women with
singleton pregnancies at risk of preterm delivery to be
treated with a combination of corticosteroids with
thyrotropin-releasing hormone [33], and the proportion
of breech deliveries carried out by caesarean section
[32]. The main reasons for excluding these indicators
were: the first is an intervention no longer used in clin-
ical practice, and the existing evidence on the second is
controversial in nature.
Table 2 General structure of an indicator
Element Description Source of information
a. Title Brief statement of what is to be assessed Research team
b. Type of Indicator • Process indicator Clinical recommendation
based on SR
• Specific indicator of general or medical condition
• Indicator of desirable or undesirable events
• Indicator based on proportions or means
c. Definitions 1. Clinical recommendation (PICO format):
Clinical situation, population, intervention,
comparison and main outcomes
Clinical recommendation
based on SR, ICD-9-CM
• Operational definition of clinical terms in
the research question
• Definition of contraindications to treatment
(if necessary)
• Description of the diagnostic and procedure
codes ICD-9-CM for the identification of the population
d. Target population Definition of the target population Clinical recommendation
based on SR
e. Rationale • Impact of the clinical condition of interest SR, CPG
• Brief description of the selected SR
• Summary of the main benefits and/or harms
associated with the intervention
• Support of the recommendation by main
clinical practice guidelines (CPG)
f. Supporting literature Main bibliography that supports the indicator
(SR and CPG)
SR, CPG
g. Description of indicator population Operational definition of the indicator (formula) Clinical recommendation
based on SR, clinical experts
• Numerator / denominator
• Exclusion criteria
h. Sources of information Description of the sources of information to
compute the indicator:
Clinical experts
• Administrative databases (mainly from inpatient
and surgical area)
• Clinical documentation (medical history)
• Other (survey, etc.)
i. Standard Definition of the standard: Clinical recommendation
based on SR
• Desirable event (↑)
• Undesirable event (↓)
j. Underlying factors • Factors related to the target population SR, CPG, Clinical experts
• Factors related to professionals
• Factors related to the hospital
k. Notes Other aspects that complement the information
summarized by the indicator.
Clinical experts
l. Desired characteristics of a
hospital to ensure the viability
of the indicator
• Essential features (associated with the identification
of the denominator and the numerator)
Clinical experts
• Desirable features (associated with an acceptable time
investment to measure it)
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Figure 1 Short title: Study’s flowchart. Detailed legend: Flowchart
of studies identified in the bibliographic search.
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Table 3. These indicators are intended to assess the de-
livery of care during the antepartum period (8 indicators
[22-30]), during delivery (8 indicators [21,31,34-40]), at
the immediate postpartum (one indicator [41]), and the
management of miscarriages (one indicator [42]).Indicators are expressed in proportions and refer to
process of care, while none refer to structure or out-
come. To illustrate the process (see Additional file 2:
Table S5) presents the full content of one indicator
(proportion of women with singleton pregnancies and
threatened preterm labour who receive corticosteroids)
and includes an example of its computation.
In 2011, we consulted the Cochrane Library in order
to verify the updating status of SR that supports the in-
dicators: all of them have been updated between 2009
and 2011. Three SR changed their conclusions; however
none of those changes invalidate the indicators. The first
SR, about using antibiotics in women with preterm rup-
ture of membranes, concludes that despite the benefits
at short term, during pregnancy, users should be aware
of the unknown long term effects on newborns. The sec-
ond SR, which likewise assesses the use of antibiotics in
prophylaxis during caesarean section, provided a similar
warning about the unknown long term effects in new-
borns. The third SR, about active versus expectant man-
agement in the third stage of labour, found potential
adverse effects with several uterotonics and concludes
that information about the benefits and harms should be
provided in order to support an informed choice.
Discussion
The degree of justification or appropriateness of an
intervention is directly related to the scientific evidence
that supports its implementation and use in practice.
Consequently, it seems logical to generate quality indica-
tors through an explicit and systematic process and this
has been our purpose. Other recent studies that have
developed indicators in a variety of fields, including per-
formance measures [19], clinical practice guidelines
[44-46], or a mixed process of evidence appraisal and
expert opinion [47,48], have been published. However, to
our knowledge, the present study is unique in its focus
on SRs.
Several authors warned about potential errors that
could be made using quality indicators [49,50]. The most
common criticism warns against a construction of qual-
ity indicators that is too mechanical. Such a construction
would infringe upon the principle that clinical decisions
should be flexible in nature, with a lack of individual
assessment of each patient and circumstances before
applying a particular intervention. Other concerns high-
light potential consequences of inflexibility resulting
from dichotomizing quality of care into adequate or
inadequate in relation to a particular practice, and fre-
quent methodological errors made in the design and
construction of indicators [14].
SRs are one of the main instruments for synthesizing
available evidence, although they remain little used to
generate healthcare explicit quality indicators. In this
Table 3 Quality of care indicators generated in the project
Indicator Target population ICD-9 codesa Indicator formulab Standardc
1 Proportion of women with
singleton pregnancies and
threatened preterm labour (TPL)
who receive corticosteroids25












2 Proportion of women who are
treated with calcium channel
blockers (CCB) for inhibiting
preterm labour26












3 Proportion of women with threatened
preterm labour treated with
magnesium sulphate27









N: Women who received magnesium
sulphate
E: None
4 Proportion of women with preterm
rupture of membranes (PRM) who
receive antibiotic treatment28
Women with PRM 658.10, 658.11 D: Pregnancies





5 Proportion of women with post-term













6 Proportion of women with severe




642.5 D: Women with severe
pre-eclampsia
≈100




7 Proportion of women with eclampsia
treated with magnesium sulphate22,23,24
Women with eclampsia 642.6 D: Women with eclampsia ≈100




8 Proportion of women with term
pregnancies and a breech presentation




73.91 D: Breech presentation ≈100
N: Women in whom
cephalic version was performed
or offered
E: None
9 Proportion of unjustified episiotomies34 Women in whom
episiotomy was
performed
73.6 D: Women in who episiotomy
was performed
≈0
N: Procedures without any
reason documented
E: None
10 Proportion of women whose
second-degree perineal tear or
Women with second-




D: Women with second-degree
perineal tear or episiotomy
≈100
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Table 3 Quality of care indicators generated in the project (Continued)
episiotomy is repaired with
continuous suture35




11 Proportion of women who are
given an enema during labour36
Women in labour 641.X1, 642.X1,
676.X1
D: Women in labour ≈0
N: Women who were
given an enema
E: None
12 Proportion of women having
perineal shaving on admission
to the delivery room37
Women in labour 641.X1, 642.X1,
676.X1
D: Women in labour ≈0




13 Proportion of women who
are administered uterotonics
in the third stage of labour38
Women in labour 641.X1, 642.X1,
676.X1
D: Women in labour ≈100





14 Proportion of women undergoing




74.XX D: Women who received
caesarean
≈100
N: Women who received
antibiotics
E: None
15 Proportion of women whose




74.XX D: Women who received
caesarean
≈0
N: Women for who
peritoneum was sutured
E: None
16 Proportion of health professionals
who use double gloves when





None D: Health professionals who performed
surgical procedures in woman with a blood-
borne disease
≈100
N: Health professionals who used double
gloves
E: None
17 Proportion of Rh-negative women
who are given Anti-D within 72




None D: Rh-negative women
with Rh-positive newborn
≈100
N: Women who received Anti-D
E: Women with prior Rh
sensitization.
18 Proportion of women with
incomplete miscarriage who,
if a surgical evacuation of retained




634.X1 -638.X1 D: Women with incomplete miscarriage ≈100
N: Women in who vacuum aspiration was
performed
E: Contraindication to vacuum aspiration
a In this column, the value “X” means any number between 0 to 9.
b In this column, (D) Denominator, (N) Numerator (E) Exclusion criteria.
c Theoretical standards: 100% means a desirable event (higher values indicate appropriate performance) and 0% an undesirable event (lower values indicate
inappropriate performance).
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based on two basic and differentiated approaches. First,
the use of good quality SRs: in this case, predominantly
Cochrane reviews as the primary source of evidence to
identify interventions for which the potential benefits far
outweigh the possible drawbacks; reviews in which that
positive balance is not sufficiently significant were ex-
cluded. Priority was given to updated secondary sources of
literature, so it is unlikely that any subsequent landmark
clinical trials for the proposed indicators were missed.
Second, a rigorous and systematic process was con-
ducted to extract relevant data from each review, and
the strength of recommendations was assessed by a
standardized method (GRADE) [16] to construct each
indicator. Only high-quality evidence was considered
and this resulted in a strong recommendation (in favour
of, or against, the intervention) for the generation of in-
dicators. It implies, according to the GRADE system,
that most patients should receive the recommended
intervention, or that it can be adopted as a policy in
most situations [16]. Moreover, discussions with the ob-
stetric consultants and SR authors resulted in improving
additional aspects in the formulation, interpretation and
applicability of the indicators. This might be considered
a more informal consultation process than other meth-
odologies, such as the aforementioned RAND Corpor-
ation approach [11]. Focusing, however, only on highly
evidence-based interventions decreases the need to con-
sult experts.
At the end of the process, 18 quality indicators for the
delivery of obstetric care in hospitals were identified. Il-
lustrated in Table 2, each proposed indicator has a clear
definition, including specific inclusion and exclusion cri-
teria that are consistent with those used in the studies
that are the source of evidence, and establishes the
population that could benefit from each intervention.
All aspects that need to be taken into account for the
use of the indicator are described, including clinical situ-
ations in which an intervention might not be suitable for
a particular patient, meaning that the patient must be
excluded from the calculation of the indicator. The pos-
sible rejection of the intervention by the patient has also
been considered in the formulation of each indicator.
This strategy permits one to overcome the classical ten-
sion between the generic approach that usually has rec-
ommendations contained in a policy document (e.g., a
clinical guideline) and the necessity of providing person-
alized care to individuals who are different. In our opin-
ion, only with such an approach can the evaluation of
quality of care provided be made, taking the existing evi-
dence and the characteristics and values of each patient
simultaneously into account.
The 18 generated indicators represent a conservative
sample of the available evidence, since the criteria ofconsistency, meaningfulness and applicability had prior-
ity. We do not expect them to be unique; however, we
propose that they should be included in any quality as-
sessment or performance measurement that is made re-
lating to the delivery of care. Since they have been
formulated while taking criteria of flexibility and feasibil-
ity into account, they could be applied in very different
hospital obstetric settings [51].
Some potential limitations of the present study should
be noted. First, since indicators help to identify quality
problems over time, their applicability and usefulness
may depend on the evolving needs of their potential
users: policy-makers, health professionals, medical soci-
eties, etc., and, theoretically, indicators that specifically
address all the issues that are relevant for different stake-
holders should be available. However, one characteristic
of our methodology is that we have generated indicators
based on strong evidence, which should be equally im-
portant for all involved parties (e.g., assessing that an
episiotomy was not performed unless justified). Second,
the identified indicators reflect only those aspects of care
that are supported by adequate evidence, which do not
necessarily cover all the desirable dimensions; however,
the reviews represented in the Cochrane Pregnancy and
Childbirth Group encompass the most used interven-
tions in the field. Therefore, the results of the present
study are very specific (a limited number, if any, of the
generated indicators are false positives in relation to
their capacity for measuring quality of care) but probably
less sensitive (some indicators could be lacking due to
the aforementioned limitations) in relation to all possible
cases. Third, the rigour applied in our methodology for
defining indicators, necessary to guarantee its internal
validity, might limit its external validity or applicability
in clinical practice. Strictly defining the target population
might reduce its applicability, leaving out large groups of
people for whom an indicator is not suitable. Finally, cal-
culation of detailed indicators in daily practice might in-
volve the need for accurate information systems and is
quite sensitive to the quality of clinical data registration.
If clinicians know in advance the criteria applied for cal-
culating quality indicators, they will likely be more aware
of the actions that must be considered in each clinical
scenario and the necessity of registering them or justify-
ing an alternative. Indicators could not only be included
in local clinical guidelines, but could also be part of
electronic alarms or clinical reminders to be activated
when the hospital information system detects one of the
situations labelled as a priority (e.g., reminding the admin-
istration of antibiotics when a caesarean section is
programmed). Future research should concentrate on
establishing the corresponding standards for the proposed
indicators and interpreting the influence of local circum-
stances and patient preferences on their observed values.
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The present study demonstrated that the generation of
healthcare quality indicators from SRs is feasible and
efficient. This is not a simple process, and not all reviews
are equally useful in generating indicators. We believe
that the thoroughness of the proposed methodology
makes these indicators essential references to assess the
extent to which the delivery of care is based on scientific
evidence. We propose that this methodology be applied
to other areas of care where there is sufficiently sound
evidence.
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